A case of amoebic liver abscess that developed during triple therapy for chronic hepatitis C

Kazufumi Dohmen, Hirofumi Tanaka, Masatora Haruno, Hiroshi Otoba, Shinji Shimoda

研究成果: ジャーナルへの寄稿記事

抄録

Triple therapy comprising telaprevir, pegylated interferon (PegIFN) and ribavirin was administered to a 58-year-old male with a high viral load of chronic serotype 1 hepatitis C. One month after the treatment, HCVRNA was undetected in the serum. However, four months after the start of administration, he developed a fever, loss of appetite and right hypochondrial pain. A laboratory examination revealed an elevated white blood cell count of 9,100 /μl and an increased concentration of C-reactive protein of 15.17 mg/dl. Ultrasonography and a computed tomography scan revealed hypoechoic and low density space-occupying lesions (SOLs) in the liver. The triple therapy was discontinued, and was replaced by antibiotics. However, the fever persisted and the SOLs in the liver became enlarged, part of which ruptured into the peritoneal cavity. Anti-amoebic antibodies were detected, and aspirated fluid of high viscosity was found to be creamy with a whitish and light yellow-greenish color, from which large number of Entamoeba histolytica trophozoites were isolated. Therefore, a diagnosis of amoebic liver abscesses was confirmed. The administration of metronidazole and catheter drainage were performed promptly. The fever disappeared and the SOLs in the liver diminished. Based on a repeat interview, a colonoscopy was performed, and the patient was confirmed to have developed aphthoid colitis five months before the administration of triple therapy. The aphthoid colitis was likely to be due to Entamoeba histolytica. Clinicians should be aware that an amoebic liver abscess can develop as an adverse effect during triple therapy for chronic hepatitis C, and a rapid diagnosis and attentive interviews were important in the present case to ensure that the patient's condition did not deteriorate.

元の言語英語
ページ(範囲)787-795
ページ数9
ジャーナルActa Hepatologica Japonica
54
発行部数11
DOI
出版物ステータス出版済み - 1 1 2013

Fingerprint

Amoebic Liver Abscess
Chronic Hepatitis C
Entamoeba histolytica
Fever
Colitis
Interviews
Therapeutics
Trophozoites
Hepatomegaly
Ribavirin
Liver
Metronidazole
Peritoneal Cavity
Appetite
Colonoscopy
Hepatitis C
Viral Load
Leukocyte Count
Viscosity
C-Reactive Protein

All Science Journal Classification (ASJC) codes

  • Hepatology

これを引用

A case of amoebic liver abscess that developed during triple therapy for chronic hepatitis C. / Dohmen, Kazufumi; Tanaka, Hirofumi; Haruno, Masatora; Otoba, Hiroshi; Shimoda, Shinji.

:: Acta Hepatologica Japonica, 巻 54, 番号 11, 01.01.2013, p. 787-795.

研究成果: ジャーナルへの寄稿記事

Dohmen, Kazufumi ; Tanaka, Hirofumi ; Haruno, Masatora ; Otoba, Hiroshi ; Shimoda, Shinji. / A case of amoebic liver abscess that developed during triple therapy for chronic hepatitis C. :: Acta Hepatologica Japonica. 2013 ; 巻 54, 番号 11. pp. 787-795.
@article{18b1bbdaa76e4aa5ae47569b610d83cf,
title = "A case of amoebic liver abscess that developed during triple therapy for chronic hepatitis C",
abstract = "Triple therapy comprising telaprevir, pegylated interferon (PegIFN) and ribavirin was administered to a 58-year-old male with a high viral load of chronic serotype 1 hepatitis C. One month after the treatment, HCVRNA was undetected in the serum. However, four months after the start of administration, he developed a fever, loss of appetite and right hypochondrial pain. A laboratory examination revealed an elevated white blood cell count of 9,100 /μl and an increased concentration of C-reactive protein of 15.17 mg/dl. Ultrasonography and a computed tomography scan revealed hypoechoic and low density space-occupying lesions (SOLs) in the liver. The triple therapy was discontinued, and was replaced by antibiotics. However, the fever persisted and the SOLs in the liver became enlarged, part of which ruptured into the peritoneal cavity. Anti-amoebic antibodies were detected, and aspirated fluid of high viscosity was found to be creamy with a whitish and light yellow-greenish color, from which large number of Entamoeba histolytica trophozoites were isolated. Therefore, a diagnosis of amoebic liver abscesses was confirmed. The administration of metronidazole and catheter drainage were performed promptly. The fever disappeared and the SOLs in the liver diminished. Based on a repeat interview, a colonoscopy was performed, and the patient was confirmed to have developed aphthoid colitis five months before the administration of triple therapy. The aphthoid colitis was likely to be due to Entamoeba histolytica. Clinicians should be aware that an amoebic liver abscess can develop as an adverse effect during triple therapy for chronic hepatitis C, and a rapid diagnosis and attentive interviews were important in the present case to ensure that the patient's condition did not deteriorate.",
author = "Kazufumi Dohmen and Hirofumi Tanaka and Masatora Haruno and Hiroshi Otoba and Shinji Shimoda",
year = "2013",
month = "1",
day = "1",
doi = "10.2957/kanzo.54.787",
language = "English",
volume = "54",
pages = "787--795",
journal = "Acta Hepatologica Japonica",
issn = "0451-4203",
publisher = "Japan Society of Hepatology",
number = "11",

}

TY - JOUR

T1 - A case of amoebic liver abscess that developed during triple therapy for chronic hepatitis C

AU - Dohmen, Kazufumi

AU - Tanaka, Hirofumi

AU - Haruno, Masatora

AU - Otoba, Hiroshi

AU - Shimoda, Shinji

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Triple therapy comprising telaprevir, pegylated interferon (PegIFN) and ribavirin was administered to a 58-year-old male with a high viral load of chronic serotype 1 hepatitis C. One month after the treatment, HCVRNA was undetected in the serum. However, four months after the start of administration, he developed a fever, loss of appetite and right hypochondrial pain. A laboratory examination revealed an elevated white blood cell count of 9,100 /μl and an increased concentration of C-reactive protein of 15.17 mg/dl. Ultrasonography and a computed tomography scan revealed hypoechoic and low density space-occupying lesions (SOLs) in the liver. The triple therapy was discontinued, and was replaced by antibiotics. However, the fever persisted and the SOLs in the liver became enlarged, part of which ruptured into the peritoneal cavity. Anti-amoebic antibodies were detected, and aspirated fluid of high viscosity was found to be creamy with a whitish and light yellow-greenish color, from which large number of Entamoeba histolytica trophozoites were isolated. Therefore, a diagnosis of amoebic liver abscesses was confirmed. The administration of metronidazole and catheter drainage were performed promptly. The fever disappeared and the SOLs in the liver diminished. Based on a repeat interview, a colonoscopy was performed, and the patient was confirmed to have developed aphthoid colitis five months before the administration of triple therapy. The aphthoid colitis was likely to be due to Entamoeba histolytica. Clinicians should be aware that an amoebic liver abscess can develop as an adverse effect during triple therapy for chronic hepatitis C, and a rapid diagnosis and attentive interviews were important in the present case to ensure that the patient's condition did not deteriorate.

AB - Triple therapy comprising telaprevir, pegylated interferon (PegIFN) and ribavirin was administered to a 58-year-old male with a high viral load of chronic serotype 1 hepatitis C. One month after the treatment, HCVRNA was undetected in the serum. However, four months after the start of administration, he developed a fever, loss of appetite and right hypochondrial pain. A laboratory examination revealed an elevated white blood cell count of 9,100 /μl and an increased concentration of C-reactive protein of 15.17 mg/dl. Ultrasonography and a computed tomography scan revealed hypoechoic and low density space-occupying lesions (SOLs) in the liver. The triple therapy was discontinued, and was replaced by antibiotics. However, the fever persisted and the SOLs in the liver became enlarged, part of which ruptured into the peritoneal cavity. Anti-amoebic antibodies were detected, and aspirated fluid of high viscosity was found to be creamy with a whitish and light yellow-greenish color, from which large number of Entamoeba histolytica trophozoites were isolated. Therefore, a diagnosis of amoebic liver abscesses was confirmed. The administration of metronidazole and catheter drainage were performed promptly. The fever disappeared and the SOLs in the liver diminished. Based on a repeat interview, a colonoscopy was performed, and the patient was confirmed to have developed aphthoid colitis five months before the administration of triple therapy. The aphthoid colitis was likely to be due to Entamoeba histolytica. Clinicians should be aware that an amoebic liver abscess can develop as an adverse effect during triple therapy for chronic hepatitis C, and a rapid diagnosis and attentive interviews were important in the present case to ensure that the patient's condition did not deteriorate.

UR - http://www.scopus.com/inward/record.url?scp=84940316826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940316826&partnerID=8YFLogxK

U2 - 10.2957/kanzo.54.787

DO - 10.2957/kanzo.54.787

M3 - Article

AN - SCOPUS:84940316826

VL - 54

SP - 787

EP - 795

JO - Acta Hepatologica Japonica

JF - Acta Hepatologica Japonica

SN - 0451-4203

IS - 11

ER -